Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Colitis, Ulcerative × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 12 Myelodysplastic Syndromes 8 Lung Neoplasms 4 Leukemia, Myelomonocytic, Chronic 4 Myeloproliferative Disorders 3 Head and Neck Neoplasms 3 Breast Neoplasms 3 Stomatitis 2 Sarcoma 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Mucositis 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Disease 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostate Cancer Metastatic 1 Primary Myelofibrosis 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Mouth Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

etrolizumab 4 Infliximab 2 golimumab 1 Papillomavirus Vaccines 1 Mesalamine 1 Injections 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Andrographis paniculata extract 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02136069 2021-12-03

GARDENIA

Hoffmann-La Roche

Phase 3 Completed

397 enrolled 32 charts

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡